Fintel reports that on February 10, 2025, Barclays downgraded their outlook for Illumina (NasdaqGS:ILMN) from Equal-Weight to ...

with best-in-class therapeutic index and beyond, today announced it has entered into a licensing agreement with Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

Xi’s government swung back almost immediately after US levies came into force, dashing hopes that Beijing would reach a deal ...

From 2020 through 2024, the S&P Biotechnology Select Industry Index decreased in value ... With an installed base of more than 25,000 sequencing systems, Illumina holds around 80% of the global ...

The country’s market regulator has initiated an investigation into technology giant Google on suspected violation of ...

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing ...

Supply Lines is a daily newsletter that tracks global trade. Sign up here.Most Read from BloombergNew York’s First ‘Passive ...

China is being restrained because it "has more to lose," due to its huge trade imbalance with the US, according to Larry Hu, ...